-
𝐇𝐮𝐦𝐚𝐧 𝐌𝐢𝐥𝐤 𝐎𝐥𝐢𝐠𝐨𝐬𝐚𝐜𝐜𝐡𝐚𝐫𝐢𝐝𝐞𝐬: 𝐏𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡 𝐢𝐧 𝐈𝐧𝐟𝐚𝐧𝐭 𝐍𝐮𝐭𝐫𝐢𝐭𝐢𝐨𝐧
𝐋𝐞𝐭’𝐬 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐟𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐟𝐨𝐨𝐝𝐬 𝐭𝐨𝐠𝐞𝐭𝐡𝐞𝐫! https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=220134357
The Human Milk Oligosaccharides (HMO) market is thriving, driven by heightened global health awareness and growing demand for infant formulas.
As consumers prioritize nutritional benefits, exploring alternative sources and overcoming production challenges are key to meeting evolving demands.
The global Human milk oligosaccharides market is projected to reach USD 556 million by 2027, recording a CAGR of 22.7%.
Human milk oligosaccharides (HMOs) are among the major components of human milk, which is packed with essential nutrients to support human health.
Some of the major types of HMOs are 2’FL, 3’FL, 3’SL, and 6’SL. On account of their numerous health benefits and a wide array of applications, 2’FL-based HMOs have become popular over the past few years.
The introduction of HMO-based consumable products and the commercialization of the use of HMOs for industrial production are some of the major driving factors responsible for the overall growth of the human milk oligosaccharides market.
Key players in this market include DSM (Netherlands), BASF (Germany), CHR Hansen Holding A/S (Denmark), Dupont (US), and Nestle (Switzerland).
#HMO #InfantNutrition #HealthAwareness #FunctionalFoods
linkedin.com
Human Milk Oligosaccharides: Seizing Growth Amid Health Awareness and Infant Formula Demand
The global market for Human Milk Oligosaccharides (HMO) is witnessing substantial growth, driven by their increasing use in functional foods and infant formulas. This article delves into the dynamics, challenges, and opportunities shaping the HMO market landscape.
